# Safety and Immunogenicity of Rotavirus Vaccine (RotaTeq(R)) in Infants With Short Bowel Syndrome

> **NCT00767364** · PHASE1 · COMPLETED · sponsor: **Children's Hospital of Michigan** · enrollment: 8 (actual)

## Conditions studied

- Short Bowel Syndrome

## Interventions

- **BIOLOGICAL:** Oral, live, pentavalent rotavirus vaccine; RotaTeq(R)

## Key facts

- **NCT ID:** NCT00767364
- **Lead sponsor:** Children's Hospital of Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2012-10
- **Final completion:** 2013-11
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2014-06-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00767364

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00767364, "Safety and Immunogenicity of Rotavirus Vaccine (RotaTeq(R)) in Infants With Short Bowel Syndrome". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00767364. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*